Browsing Tag
Siddharth Mittal
8 posts
Biocon joins forces with Tabuk Pharmaceuticals to bring GLP-1 diabetes drugs to Middle East
In a strategic move to tackle the growing diabetes crisis in the Middle East, Biocon Limited has announced…
September 29, 2024
Biocon and Juno Pharmaceuticals ink game-changing diabetes drug deal
Biocon Limited, the innovation-driven global biopharmaceutical frontrunner, has made headlines by sealing a significant partnership agreement with Juno…
October 7, 2023
Biocon Generics acquires US facility for $7.7m, targets two billion tablet capacity
Biocon Limited, a global leader in the biopharmaceutical industry, has made a landmark announcement: its wholly-owned subsidiary, Biocon…
September 2, 2023
Biocon partners with Zentiva for European marketing of Liraglutide
Biocon Limited has entered into a semi-exclusive partnership with Zentiva, a Czech pharma company for marketing its drug-device…
November 29, 2022
Biocon Q4FY22 results : Indian pharma firm net profit down by 6% to Rs 239cr
Biocon Q4FY22 results : Biocon Ltd has reported a net profit of INR 239 crores for the fourth…
April 28, 2022
Biocon ties-up with Tabuk to bring specialty generic products in Middle East
Indian pharma company Biocon Limited has forged a partnership with Tabuk Pharmaceutical Manufacturing Company to commercialize certain specialty…
December 7, 2021
Biocon, Libbs Farmaceutica team up for launching generic drugs in Brazil
Biocon Ltd, an Indian biopharma company, has entered into a partnership with Brazilian pharma company Libbs Farmaceutica for…
March 30, 2021
Biocon launches generic Tacrolimus in U.S.: A gamechanger in transplant care
Find out how Biocon’s launch of generic Tacrolimus in the U.S. marks a strategic leap in affordable transplant care and global generic market expansion.
December 30, 2020